|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��״IgA������Ƥ�� |
|
��� |
|
���� |
| ��������������� | |
|
���տ� |
|
����Ӣ |
|
���� |
| PubMed | |
|
Article by LIU Su-jun |
|
Article by FENG Su-ying |
|
Article by LIN Lin |
��״IgA������Ƥ�������о���չ
���տ�, ����Ӣ, ����
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о��� �Ͼ� 210042
��״IgA������Ƥ����һ���ټ������������Ա�Ƥ�´��岡,��ȷ�еķ������ƻ�������������İп�ԭ��LAD97��LAD-1��BP180��BP230��LAD285�ȿ�ԭ,����BP180��ԭ�����ڷ����������á������ԵĻ���Ĥ����״IgA�������Ϊȷ�ﱾ������Ҫ���ݡ�����������Ƶ���ѡҩ�
Linear IgA Bullous Dermatosis
Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China
Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China
Linear IgA bullous dermatosis is a rare autoimmune subepidermal bullous disease. The exact pathogenesis is unknown yet. The common target antigens are LAD97, LAD-1, BP180, BP230 and LAD285. BP180 antigen may play a key role in the pathogenesis. Linear IgA antibody depositing at the basal membrane zone is the major diagnostic evidence. Dapsone is the first choice for its therapy.
[2] Egan CA,Zone JJ.Linear IgA bullous dermatosis.Iht J Dermatol,1999,38:818-827.
[3] Salmhofer W,Soyer HP,Wolf P,et al.UV light-induced linear IgA dermatosis.J Am Acad Dermatol,2004,50:109-115.
[4] Armstrong AW,Fazeli A,Yeh SW,et al.Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme.J Cutan Pathol,2004,31:393-397.
[5] Perrett CM,Evans AV,Russell-Jones R.Tea tree oil dermatitis associated with linear IgA disease.Clin Exp Dermatol,2003,28:167-170.
[6] Girao L,Fiadeiro T,Rodrigues JC.Burn-induced linear IgA dermatosis.J Eur Acad Dermatol Venereol,2000,14:507-510.
[7] Cooke N,Jenkinson H,Wojnarowska F,et al.Coexistence of psoriasis and linear IgA disease in apatient with recent herpes zoster infection.Clin Exp Dermatol,2005,30:643-645.
[8] Zone JJ.Clinical spectrum,pathogenesis and treatment of linear IgA bullous dermatosis.J Dermatol,2001,28:651-653.
[9] Allen J,Wojnarowska F.Linear IgA disease:the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies,and is more common in adults.Br J Dermatol,2003,149:977-985.
[10] Allen J,Wojnarowska F.Linear IgA disease:the IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180-kDa protein.Br J Dermatol,2003,149:1055-1058.
[11] Zillikens D.BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.Keio J Med,2002,51:21-28.
[12] Zillikens D,Herzele K,Georgi M,et al.Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.J Invest Dermatol,1999,113:947-953.
[13] Georgi M,Scheckenbach C,Kromminga A,et al.Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease.Arch Dermatol Res,2001,293:109-114.
[14] Zhou S,Ferguson DJ,Allen J,et al.The localization of target antigens and autoantibodies in linear IgA disease is variable:correlation of immunogold electron microscopy and immunoblotting.Br J Dermatol,1998,139:591-597.
[15] Lin MS,Fu CL,Olague-Marchan M,et al.Autoimmune responses in patients with linear IgA bullous dermatosis:both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.Clin Immunol,2002,102:310-319.
[16] Caproni M,Rolfo S,Bernacchi E,et al.The role of lymphocytes,granulocytes,mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis.Br J Dermatol,1999,140:1072-1078.
[17] Eguia del Valle A,Aguirre Urizar JM,Martinez Sahuquillo A.Oral manifestations caused by the linear IgA disease.Med Oral,2004,9:39-44.
[18] Vodegel RM,de Jong MC,Pas HH,et al.IgA-mediated epidermolysis bullosa acquisita:two cases and review of the literature.J Am Acad Dermatol,2002,47:919-925.
[19] Osawa M,Demitsu T,Toda S,et al.A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis.Dermatology,2005,211:146-148.
[20] Farley-Li J,Mancini AJ.Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil.Arch Dermatol,2003,139:1121-1124.
[21] Talhari C,Mahnke N,Ruzicka T,et al.Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.Clin Exp Dermatol,2005,30:297-298.